Post-traumatic Stress Disorder, Cocaine Use, and HIV Persistence

scientific article published on 01 October 2019

Post-traumatic Stress Disorder, Cocaine Use, and HIV Persistence is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S12529-019-09804-4
P932PMC publication ID7142331
P698PubMed publication ID31313251

P50authorAdam CarricoQ88523191
Allan E RodriguezQ90102626
P2093author name stringMario Stevenson
Mark Sharkey
Michael H Antoni
Tiffany R Glynn
Jessica Salinas
Olorunleke Oni
Danita Jemison
P2860cites workRecent stimulant use and leukocyte gene expression in methamphetamine users with treated HIV infection.Q52572947
Novel Latency Reversal Agents for HIV-1 Cure.Q52816327
CD4 T cell nadir independently predicts the magnitude of the HIV reservoir after prolonged suppressive antiretroviral therapy.Q53211334
Sustained urinary norepinephrine and epinephrine elevation in post-traumatic stress disorder.Q53775784
HIV: Shock and kill.Q55056512
Stimulant Use and Viral Suppression In the Era of Universal Antiretroviral TherapyQ57071235
PD-1 blockade potentiates HIV latency reversal ex vivo in CD4 T cells from ART-suppressed individualsQ64252705
HIV Viral Suppression Trends Over Time Among HIV-Infected Patients Receiving Care in the United States, 1997 to 2015: A Cohort Study.Q64921701
Psychosocial Correlates of Monocyte Activation and HIV Persistence in Methamphetamine UsersQ90481968
How does the timing of antiretroviral therapy initiation in acute infection affect HIV reservoirs?Q26822422
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferationQ29619611
Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorderQ33772700
A simple single-item rating scale to measure medication adherence: further evidence for convergent validityQ34462551
Stimulant use and progression to AIDS or mortality after the initiation of highly active antiretroviral therapyQ34513996
Comparative analysis of measures of viral reservoirs in HIV-1 eradication studiesQ34607763
Towards an HIV cure: a global scientific strategyQ34640562
Enhanced replication of simian immunodeficiency virus adjacent to catecholaminergic varicosities in primate lymph nodes.Q34647468
An internationally generalizable risk index for mortality after one year of antiretroviral therapy.Q34813110
HIV DNA reservoir increases risk for cognitive disorders in cART-naïve patientsQ34922069
Cocaine modulates HIV-1 integration in primary CD4+ T cells: implications in HIV-1 pathogenesis in drug-abusing patientsQ35207116
Addiction motivation reformulated: an affective processing model of negative reinforcementQ35645919
Psychosocial and Neurohormonal Predictors of HIV Disease Progression (CD4 Cells and Viral Load): A 4 Year Prospective StudyQ35736120
Methamphetamine Use in HIV-infected Individuals Affects T-cell Function and Viral Outcome during Suppressive Antiretroviral Therapy.Q35990287
Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysisQ36747893
Cell-associated HIV RNA: a dynamic biomarker of viral persistenceQ36798408
Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women.Q37104874
Role of depression, stress, and trauma in HIV disease progressionQ37180015
Prevalence and correlates of substance use among youth living with HIV in clinical settings.Q37478571
Substance use and HIV disease progression in the HAART era: Implications for the primary prevention of HIVQ37799090
Psychological trauma and PTSD in HIV-positive women: a meta-analysisQ37976387
HIV reservoirs: pathogenesis and obstacles to viral eradication and cureQ37999624
HIV therapy-the state of art.Q38395370
Urinary catecholamine excretion and severity of PTSD symptoms in Vietnam combat veterans.Q41118221
HIV reservoirs as obstacles and opportunities for an HIV cureQ41216521
Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure.Q41880147
Cocaine dependence with and without PTSD among subjects in the National Institute on Drug Abuse Collaborative Cocaine Treatment StudyQ42054863
Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United StatesQ43694055
Relation of lifetime trauma and depressive symptoms to mortality in HIV.Q44363402
Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapyQ44692012
Posttraumatic stress disorder symptoms, salivary cortisol, medication adherence, and CD4 levels in HIV-positive individualsQ44693769
Affect regulation, stimulant use, and viral load among HIV-positive persons on anti-retroviral therapyQ46159115
Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scaleQ46572937
Validation of the World Health Organization Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): report of results from the Australian siteQ46646611
Psychiatric co-morbidity in vulnerable populations receiving primary care for HIV/AIDS.Q46702797
What do we measure when we measure cell-associated HIV RNA.Q47548192
Substance-associated elevations in monocyte activation among methamphetamine users with treated HIV infectionQ47549005
Posttraumatic stress disorder and drug disorders: testing causal pathways.Q50861285
Understanding comorbidity between PTSD and substance use disorders: two preliminary investigations.Q51594607
Cocaine dependence with and without post-traumatic stress disorder: a comparison of substance use, trauma history and psychiatric comorbidity.Q51975397
P433issue5
P921main subjectpost-traumatic stress disorderQ202387
P304page(s)542-550
P577publication date2019-10-01
P1433published inInternational Journal of Behavioral MedicineQ15752478
P1476titlePost-traumatic Stress Disorder, Cocaine Use, and HIV Persistence
P478volume26

Search more.